Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Association of Polymorphisms in three pri-miRNAs that Target Pepsinogen C with the Risk and Prognosis of Gastric Cancer.

Wu YF, Xu Q, He CY, Li Y, Liu JW, Deng N, Sun LP, Yuan Y.

Sci Rep. 2017 Jan 9;7:39528. doi: 10.1038/srep39528.

2.

Pri-let-7a-1 rs10739971 polymorphism is associated with gastric cancer prognosis and might affect mature let-7a expression.

Li Y, Xu Q, Liu J, He C, Yuan Q, Xing C, Yuan Y.

Onco Targets Ther. 2016 Jul 4;9:3951-62. doi: 10.2147/OTT.S100481. eCollection 2016.

3.

Significance of microRNA-related variants in susceptibility to recurrence of oropharyngeal cancer patients after definitive radiotherapy.

Chen X, Sturgis EM, Wang C, Cao X, Li Y, Wei Q, Li G.

Oncotarget. 2016 Jun 7;7(23):35015-25. doi: 10.18632/oncotarget.9014.

4.

Identification of plasma microRNA profiles for primary resistance to EGFR-TKIs in advanced non-small cell lung cancer (NSCLC) patients with EGFR activating mutation.

Wang S, Su X, Bai H, Zhao J, Duan J, An T, Zhuo M, Wang Z, Wu M, Li Z, Zhu J, Wang J.

J Hematol Oncol. 2015 Nov 12;8:127. doi: 10.1186/s13045-015-0210-9.

5.

MicroRNA-27a directly targets KRAS to inhibit cell proliferation in esophageal squamous cell carcinoma.

Jiang Y, Duan Y, Zhou H.

Oncol Lett. 2015 Jan;9(1):471-477. Epub 2014 Nov 11.

6.

Prognostic role of common microRNA polymorphisms in cancers: evidence from a meta-analysis.

Xia L, Ren Y, Fang X, Yin Z, Li X, Wu W, Guan P, Zhou B.

PLoS One. 2014 Oct 22;9(10):e106799. doi: 10.1371/journal.pone.0106799. eCollection 2014.

7.

Lack of association between miR-27a, miR-146a, miR-196a-2, miR-492 and miR-608 gene polymorphisms and colorectal cancer.

Kupcinskas J, Bruzaite I, Juzenas S, Gyvyte U, Jonaitis L, Kiudelis G, Skieceviciene J, Leja M, Pauzas H, Tamelis A, Pavalkis D, Kupcinskas L.

Sci Rep. 2014 Aug 8;4:5993. doi: 10.1038/srep05993.

8.

Novel insights into miRNA in lung and heart inflammatory diseases.

Kishore A, Borucka J, Petrkova J, Petrek M.

Mediators Inflamm. 2014;2014:259131. doi: 10.1155/2014/259131. Epub 2014 May 27. Review.

9.

Gene polymorphisms of micrornas in Helicobacter pylori-induced high risk atrophic gastritis and gastric cancer.

Kupcinskas J, Wex T, Link A, Leja M, Bruzaite I, Steponaitiene R, Juzenas S, Gyvyte U, Ivanauskas A, Ancans G, Petrenkiene V, Skieceviciene J, Kupcinskas L, Malfertheiner P.

PLoS One. 2014 Jan 27;9(1):e87467. doi: 10.1371/journal.pone.0087467. eCollection 2014.

10.

Pre-miR-27a rs895819A/G polymorphisms in cancer: a meta-analysis.

Xu Q, He CY, Liu JW, Yuan Y.

PLoS One. 2013 Jun 7;8(6):e65208. doi: 10.1371/journal.pone.0065208. Print 2013.

11.

Cross-talk between MET and EGFR in non-small cell lung cancer involves miR-27a and Sprouty2.

Acunzo M, Romano G, Palmieri D, Laganá A, Garofalo M, Balatti V, Drusco A, Chiariello M, Nana-Sinkam P, Croce CM.

Proc Natl Acad Sci U S A. 2013 May 21;110(21):8573-8. doi: 10.1073/pnas.1302107110. Epub 2013 May 6.

12.

Polymorphisms of microRNA sequences or binding sites and lung cancer: a meta-analysis and systematic review.

Chen Z, Xu L, Ye X, Shen S, Li Z, Niu X, Lu S.

PLoS One. 2013 Apr 16;8(4):e61008. doi: 10.1371/journal.pone.0061008. Print 2013. Review.

13.

Effects of common polymorphism rs11614913 in Hsa-miR-196a2 on lung cancer risk.

Yuan Z, Zeng X, Yang D, Wang W, Liu Z.

PLoS One. 2013 Apr 12;8(4):e61047. doi: 10.1371/journal.pone.0061047. Print 2013.

Supplemental Content

Support Center